Medicine News and Research

RSS

MU researchers redefine key regulatory process in defective protein responsible for cystic fibrosis

A little more than a year after the FDA approved Kalydeco (Vx-770), the first drug of its kind to treat the underlying cause of cystic fibrosis, University of Missouri researchers believe they have found exactly how this drug works and how to improve its effectiveness in the future.

22 Mar 2013

Fibromyalgia: an interview with Dr Frederick Wolfe, University of Kansas School of Medicine

Fibromyalgia is a common disorder that is diagnosed in people who have pain in many areas of their body together with important symptoms such as...

22 Mar 2013

Blocked bile ducts can be effectively treated with metal stents

A multi-center analysis, led by Weill Cornell Medical College and published in the Journal of Clinical Gastroenterology, shows the use of temporary "fully covered self-expanding metal stents" (FCSEMS) can effectively fix a painful and potentially life-threatening benign biliary stricture -- a severely blocked or narrowed bile duct.

21 Mar 2013

Adult stem cells improve cartilage repair

Using adult stem cells is a good way of culturing better-quality cartilage to repair worn hips and knees. New cartilage that has good properties can be grown in particular by cultivating adult stem cells in combination with a small quantity of cells from the patient's own cartilage.

21 Mar 2013

HIV home tests: an interview with Dr Nitika Pant Pai, McGill University

30 years into the HIV epidemic, there is no vaccine in sight. Yet, even though there are fantastic and effective cheap and universally available drugs, and a treatment as prevention strategy is known to work, people do not wish to get tested for HIV! If everyone got tested, and treated, we could have brought the infection under control a long time ago!

21 Mar 2013

Study reveals treatments for pain at site of injury may not always be good enough

Treatments for pain at the site of an injury may not always be good enough, according to a novel study by University of Maryland (UM) scientists reported March 20 in The Journal of Neuroscience.

21 Mar 2013

Positive results from Affinium Pharmaceuticals' Phase 2a clinical trial of AFN-1252 in ABSSSI

Affinium Pharmaceuticals announced today that its Phase 2a clinical trial evaluating oral AFN-1252 in acute bacterial skin & skin structure infections demonstrated excellent efficacy and safety data, marking a significant proof-of-concept milestone for Affinium's first-in-class, novel antibiotic targeted against bacterial fatty acid biosynthesis inhibition (FabI inhibitors).

21 Mar 2013

Report on Austrian national health care system approach to psychosomatic medicine

One of the last issue of Psychotherapy and Psychosomatics has a report on the characteristics of a training program in psychosomatic medicine that places Austria in a top position in Europe.

21 Mar 2013

WUSTL's Wang receives NSF grant to study oxygen consumption rates of individual cells

When scientists study cells, they need to know how much oxygen each cell consumes to determine its metabolism. However, existing technology limits this study to groups of cells, not individual cells. Lihong Wang, PhD, plans to change that.

21 Mar 2013

TSRI receives fund to develop new field test for Onchocerciasis

Philanthropist, businessman and community leader John Moores has given The Scripps Research Institute approximately $2 million to fund the development of a new field test for Onchocerciasis, or river blindness, a parasitic infection that affects tens of millions of people in Africa, Latin America and other tropical regions.

21 Mar 2013

Investigators examine effectiveness of probiotics for cancer treatment

One may not think of probiotics -- like those found in yogurt that promote good digestive health -- as a weapon used in the fight against cancer. But that is the focus of investigators at The Cancer Institute of New Jersey, who are examining the effectiveness of probiotics as they relate to the outcomes of bone marrow transplant for patients with blood cancers.

21 Mar 2013

GlobalPost, humanitarian agencies examine impact of childhood TB

Noting the WHO and the Global Fund to Fight AIDS, Tuberculosis and Malaria on Monday issued a joint statement calling for an additional $1.6 million a year to fight tuberculosis (TB) in low- and middle-income countries, GlobalPost's "Global Pulse" blog examines the global impact of childhood TB, writing, "While health officials did not single out the devastating impact of the disease on children ... WHO estimates that at least 500,000 children contract TB each year and that 70,000 die from the disease, largely in Asia and Africa."

21 Mar 2013

Blog reports on Consortium of Universities for Global Health annual conference

The Global Health Technologies Coalition's "Breakthroughs" blog reports on the Consortium of Universities for Global Health annual conference held last week, highlighting "a panel hosted by the GHTC, which focused on current fiscal and policy realities in the United States that will impact global health research and development in the coming year and beyond."

21 Mar 2013

Study examines overuse of ER for nonemergency visits

Visits to the ER are not always for true medical emergencies - and some policymakers have been fighting the problem by denying or limiting payments if the patient's diagnosis upon discharge is for "nonemergency" conditions.

21 Mar 2013

UC San Francisco team develops online cardiovascular study to improve heart health

A UC San Francisco team has developed an ambitious online cardiovascular study using mobile smartphones, with the goal of enrolling one million people from all over the world to improve heart health.

21 Mar 2013

UC San Diego Moores Cancer Center joins alliance of world's leading cancer centers

On March 19, the National Comprehensive Cancer Network announced the election of University of California, San Diego Moores Cancer Center as the first and only San Diego-based NCCN Member Institution dedicated to improving the quality, effectiveness, and efficiency of care provided to patients with cancer.

21 Mar 2013

CPF and PFF to partner with ATS to fund pulmonary fibrosis research

The Coalition for Pulmonary Fibrosis, the Pulmonary Fibrosis Foundation, and the American Thoracic Society-the world's leading professional organization for pulmonary, critical care and sleep medicine-today announced that the CPF and the PFF will again partner with the ATS to fund pulmonary fibrosis research.

21 Mar 2013

Research findings could lead to new treatments for lung disorders in premature babies

Researchers at Yale School of Medicine have made major discoveries that could lead to new treatments for lung disorders in premature babies. In a mouse study, the team located key molecules that switch on stress pathways in preterm lung disorders, and also found that when parts of these pathways were blocked with a pain drug, lung damage was prevented or reversed.

21 Mar 2013

New imaging agent detects, maps cancers that have reached lymph nodes

Researchers at the University of California, San Diego School of Medicine have shown that a new imaging dye, designed and developed at UC San Diego Moores Cancer Center, is an effective agent in detecting and mapping cancers that have reached the lymph nodes.

21 Mar 2013

Researchers complete phase II clinical trial of dasatinib for patients with higher-risk MDS

Researchers at Moffitt Cancer Center have completed a phase II clinical trial to determine the safety and efficacy of dasatinib for patients with higher-risk myelodysplastic syndromes, chronic myelomonocytic leukemia, or acute myeloid leukemia resulting from MDS and have failed treatment with azanucleosides.

21 Mar 2013

Medicine News and Research

MU researchers redefine key regulatory process in defective protein responsible for cystic fibrosis

Fibromyalgia: an interview with Dr Frederick Wolfe, University of Kansas School of Medicine

Blocked bile ducts can be effectively treated with metal stents

Adult stem cells improve cartilage repair

HIV home tests: an interview with Dr Nitika Pant Pai, McGill University

Study reveals treatments for pain at site of injury may not always be good enough

Positive results from Affinium Pharmaceuticals' Phase 2a clinical trial of AFN-1252 in ABSSSI

Report on Austrian national health care system approach to psychosomatic medicine

WUSTL's Wang receives NSF grant to study oxygen consumption rates of individual cells

TSRI receives fund to develop new field test for Onchocerciasis

Investigators examine effectiveness of probiotics for cancer treatment

GlobalPost, humanitarian agencies examine impact of childhood TB

Blog reports on Consortium of Universities for Global Health annual conference

Study examines overuse of ER for nonemergency visits

UC San Francisco team develops online cardiovascular study to improve heart health

UC San Diego Moores Cancer Center joins alliance of world's leading cancer centers

CPF and PFF to partner with ATS to fund pulmonary fibrosis research

Research findings could lead to new treatments for lung disorders in premature babies

New imaging agent detects, maps cancers that have reached lymph nodes

Researchers complete phase II clinical trial of dasatinib for patients with higher-risk MDS

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Improving healthcare sustainability through carbon data

Managing vibration in IVF laboratories

A New Approach to Preventing Bladder Cancer Recurrence

Latest News